OBESITY =
BIGGEST
PREVENTABLE
CAUSE OF CANCER
AFTER SMOKING
CAN CAUSE 10 TYPES OF
CANCER
2 OF THE
MOST
COMMON:
BREAST &
BOWEL
2 OF THE MOST
DIFFICULT TO
TREAT:
OESOPHAGEAL
&
PANCREATIC
NEW CASES OF
CANCER: 670,000
OVER THE NEXT 20
YEARS
KEY
FINDINGS
INTRODUCTION OF 20%
SUGARY-DRINK TAX COULD
AVOID 3.7 MILLION PEOPLE
BEING OBESE BY 2025
5% SHIFT IN OBESITY
PREVALENCE
CURRENT TRENDS
CONTINUE, THERE WILL
BE A 5% INCREASE IN
PREVALENCE: FROM 29%
TO 34% BY 2025
INTRODUCTION OF TAX COULD SAVE £10M OF DIRECT NHS
HEALTH AND SOCIAL CARE COSTS IN 2025 ALONE
ALCOHOL AWARENESS
CAMPAIGN
THE
SUBSTANCE
PLAYS SIGNIFICANT
ROLE
ECONOMICALLY &
SOCIALLY
EXTENSIVE
MORBIDITY
BURDEN
ASSOCIATED
WITH ALCOHOL
USE
PROBLEM
DRINKING
OFTEN
ASSOCIATED
WIT
ALCOHOLISM
DOMESTIC
& PUBLIC
VIOLENCE
ACCIDENTS
LOSS OF
EMPLOYMENT
HOWEVER, LARGE NO. OF
PEOPLE WHO CONSUME
HAZARDOUS AMOUNTS OF
ALCOHOL WITHOUT CAUSING
SUCH 'HAVOK'
CHRONIC LIVER
DISEASE +
CIRRHOSIS HAVE
BEEN ON THE RISE
FOR THE LAST 50
YEARS
NHS LONDON SPENDS OVER £250 M A
YEAR ON ALCOHOL ATTRIBUTED
ADMISSIONS
EQUIVALENT
TO £34 FOR
EVERY
RESIDENT IN
THE CAPITAL!
HIGHEST RATE OF ALCOHOL
FOUND IN RESPONDENTS =
MANAGERIAL / PROFESSIONAL
(42.4%)
OPPORTUNITY FOR COMMUNITY PHARMACY TO
DELIVER COMMUNITY-BASED SERVICES
TRADITIONALLY PROVIDED BY GPs/HOSPITAL
OUTPATIENT CLINICS TO THOSE WISHING TO
STOP/REDUCE DRINKING
MAY IN FUTURE REDUCE HOSPITAL ADMISSION
RATES
SHOWING PROMISE IN PHARMACY
SERVICES
LONDON-WIDE COMMUNITY
PH CAMPAIGN: DELIVERY
OF AUDIT-C ALCOHOL USE
ASSESSMENT TOOL:
ACCEPTABLE TO MEN &
WOMEN OF ALL AGES &
ETHNICITIES IN LONDON
IN 3 MONTHS, OVER
240,000 SCRATCH CARDS
GIVEN OUT & OVER
23,800 RETURNED AND
RECORDED IN ONLINE
SYSTEM
43.5% RECORDED
SCORE OF =>5,
INDICATING
HIGHER RISK OF
DRINKING
FINDING SUPPORT ARGUMENTS
IN FAVOUR OF ENABLING
COMMUNITY PHARMACIES TO
DEVELOP FURTHER AS 'PUBLIC
HEALTH' OR 'HEALTHY LIVING'
CARE AND SUPPORT CENTRES
FURTHER WORK NEEDED TO
ESTABLISH MOST COST EFFECTIVE
INTERVENTIONS & REFERRAL
PRACTICES FOR PHARMACISTS
SEEKING TO HELP THOSE WISHING
TO REDUCE ALCOHOL RELATED AND
ALLIED RISK LEVELS
BEYOND THIS,
PHARMACISTS
CAN
CONTRIBUTE TO
PUBLIC AND
PERSONAL
HEALTH
IMPROVEMENTS
IN:...
SEXUAL
HEALTH
SMOKING
CESSATION
WEIGHT
MANAGEMENT
PREVENTION OF HIGHLY
PREVALENT CONDITIONS
SUCH AS OESOPHAGEAL
CANCER
HEALTH RISKS
(ALCOHOL
CONSUMPTION)
BMA REPORTED THAT
ALCOHOL CONTRIBUTES TO
OVER 60 CONDITIONS
(WHOLLY ALCOHOL
RELATED VS. CHRONIC
IN 2011, 8,748
ALCOHOL
RELATED
DEATHS IN THE
UK
CHRONIC HARM:
LONGER PERIOD
OF TIME WITH
REGULAR
DRINKING AT OR
ABOVE
RECOMMENDED
'SAFE' LIMITS
LIVER DISEASE
SEEN AS
BAROMETER OF
ALCOHOL
RELATED ILL
HEALTH
ACCOUNTS; 4 / 5
DEATHS DUE TO
LIVER CIRRHOSIS
IDENTIFYING
HARMFUL &
HAZARDOUS
DRINKING
PREVIOUS FOCUS ON
PREVENTING UNDER-AGE
DRINKING & PROVIDING HELP /
TREATMENT FOR HEAVY
DRINKERS
HOWEVER! THIS COULD
GLAMOURISE DRINKING, AND
MAKE ALCOHOL CONSUMPTION AN
EMBLEM OF ADULT STATUS
PRESENT POLICY
DOCUMENTS...
A PROACTIVE ANTICIPATORY MULTIDISCIPLINARY HARM REDUCTION
APPROACH
HARM REDUCTION
STRATEGIES
EDUCATION &
IDENTIFICATION OF
'AT-RISK' DRINKERS
COMMUNICATION
WITH CLIENTS ABOUT
IMPACT &
CONSEQUENCES OF
ALCOHOL
CONSUMPTION
USING VARIETY OF PROFESSIONALS ACROSS HEALTH &
SOCIAL CARE
IN THIS
MULTI-DISCIPLINARY/PROFESSIONAL
CONTEXT, IT IS BECOMING INCREASINGLY
RECOGNISED THAT PHARMACIES &
PHARMACISTS ARE POTENTIAL ACTORS IN
THE PH AGENDA
IDENTIFICATION OF
INDIVIDUALS THAT ARE
DRINKING BEYOND LIMITS
DEFINED AS 'SAFE''
WHO DEVELOPED AUDIT
QUESTIONNAIRE TO
CONVERT APPROACH TO
ALCOHOL MISUSE FROM
REACTIVE TO PROACTICE
TESTED AND VALIDATED IN 6
COUNTRIES, PROVED TO BE
VALUABLE SCREENING TOOL IN
BOTH PRIMARY & SECONDARY
SETTINGS
HOWEVER, AN AUDIT THAT TAKES
A SHORT AMOUNT OF TIME (30S),
SEEMED MORE VALUABLE &
LIKELY TO BECOME A ROUTINE
COMPONENT OF HEALTH & SOCIAL
INTERVENTIONS 'AUDIT-C'
ROLE OF COMMUNITY PHARMACY IN
ALCOHOL INTERVENTION
'CHOOSING HEALTH THROUGH PHARMACY':
ALCOHOL PROBLEMS COULD BE ADDRESSED BY THE
PHARMACIST
THE WHITE PAPER:
'PHARMACY-BASED
INTERACTIONS FOR
PEOPLE WITH ALCOHOL
PROBLEMS SHOULD BE
FURTHER PILOTED &
EVALUATED' (DoH)
COMMUNITY PHARMACY COULD MAKE IMPORTANT
CONTRIBUTIONS TO THE ALCOHOL PANDEMIC THROUGH
DELIVERY OF OPPORTUNISTIC ADVICE, BRIEF
INTERVENTIONS & OFFERING FLOOR SPACE TO OTHER
HEALTH PROFESSIONALS
ACCESSIBILITY & HIGH
FOOTFALL OF COMMUNITY
PHARMACY PROVIDES STAFF
WITH OPPORTUNITY TO
IDENTIFY PEOPLE WITH
RISKY DRINKING
BEHAVIOURS
MUCH POTENTIAL FOR
PHARMACISTS TO REGULARLY
AND ROUTINELY ENQUIRE
ABOUT ALCOHOL DRINKING
BEHAVIOURS
CONSUMERS WILL OFTEN
PRESENT IN PHARMACY
WITH SYMPTOMS
ASSOCIATED WITH
ALCOHOL MISUSE
SLEEPING
IRREGULARITIES,
INDIGESTION AND
GASTRIC
PROBLEMS,
REQUESTS FOR
HANGOVER 'CURES'
OR GENERALLY
FEELING RUN
DOWN
PHARMACIST
INTERVENTION
SIGNPOSTING TO LOCAL CENTRE
OFFERING PROFESSIONAL
SUPPORT OR REFERRAL TO GP
PROVISION OF LEAFLET DETAILING
INFO AND ADVICE ON SAFER
DRINKING
VITAL HEALTH
PRIORITY -
NATIONALLY &
INTERNATIONALLY
KILLED 100 M
PEOPLE IN THE
SECOND HALF OF
THE 2OTH CENTURY
& DISABLED MORE
SMOKING RATES IN
ADULTS HAVE
FALLEN FROM 60%
OF ADULTS AT THE
START OF THE 1950s
TO ~18% TODAY
IN BRITAIN TODAY, IT
IS THE MAJOR CAUSE
OF CLASS-LINKED
HEALTH
INEQUALITIES
STILL DECLINING, HOWEVER WHILE
600,000 PEOPLE STOP SMOKING EACH
YEAR, ALMOST 300,000 START USING
TOBACCO (TEENS/EARLY 20s)
CIGARETTES KILL
~1/2 OF ALL
LONG-TERM USERS
& DISABLE MANY
OF THEIR
SURVIVING USERS
HEALTH
RISKS
NICOTINE CAUSES
ADDICTION TO TOBACCO
SMOKING
HOWEVER, OTHER COMPONENTS OF
TOBACCO SMOKE ARE THE KNOWN
CAUSES OF DISEASE SUCH AS LUNG
CANCER, COPD & ,HEART ATTACKS
ALTHOUGH NICOTINE ADDICTION MAY
EXACERBATE SOME FORMS OF MENTAL
DISTRESS, IT IS NOT THE IMMEDIATE
CAUSE OF OF SMOKING RELATED DEATH
AND DISABILITY
PEOPLE WHO REMAIN
SMOKERS TODAY MAY BE
MORE ADDICTED TO
NICOTINE THAN THOSE
WHO HAVE ALREADY
QUIT
THEREFORE, WILL FIND IT HARDER TO
QUIT
SMOKERS ARE
TWICE AS LIKELY
TO SUFFER FROM A
MI THAN A NON
SMOKER
STOP
SMOKING
50% OF ALL QUIT ATTEMPTS
ARE MADE WITHOUT THE USE
OF MEDICINES AND OTHER
AIDS (INCL. E-CIGARETTES)
NICOTINE REPLACEMENT &
OTHER STOP SMOKING
MEDICINES WORK BY
RELIEVING CRAVINGS & GIVING
INDIVIDUALS TIME TO FREE
THEMSELVES FROM
BEHAVIOURAL ASPECTS OF
SMOKING
THERE IS EVIDENCE THAN COMBINATIONS OF
PRESCRIBED MEDICINES AND PSYCHOLOGICAL
SUPPORT SUPPLIED VIA THE NHS STOP SMOKING
SERVICES OR SIMILAR PROFESSIONAL SOURCES:
MORE LIKELY TO FACILITATE SUCCESSFUL
QUIT ATTEMPTS THAN OTHER APPROACHES
ALSO RECENT EVIDENCE THAT
USING E-CIGARETTES IN SUPPORTED
QUIT ATTEMPTS MAY PROVE
SIMILARLY SUCCESSFUL
HOWEVER ~90% OF E-CIGARETTE
USERS AT ANY ONE TIME REPORT
CONTINUING TOBACCO SMOKING
ALONGSIDE 'VAPING' & MAJORITY
OF THOSE WHO TRY IT, STOP AND
RETURN BACK TO SMOKING
IN SWEDEN, 'SNUS' DEMONSTRATES THE FACT THAT
ALTERNATIVE 'NON-COMBUSTION' BASED
APPROACHES TO NICOTINE DELIVERY CAN
IMPROVE PUBLIC HEALTH
RECENT DATA INDICATE THAT
E-CIGARETTES AND OTHER
UNLICENSED PRODUCTS
PROMOTED AN ADDITIONAL
20,000 SUCCESSFUL ATTEMPTS
TO STOP SMOKING 2013/2014
THERE ARE UP TO 2
MILLION 'VAPERS' IN THE
UK
NUMBER OF CURRENT SMOKERS
USING THEM IS FALLIN, BUT
NUMBER OF EX-SMOKERS USING
THEM IS RISING
MANY SMOKERS DO NOT FIND
CRAVING RELIEF WHEN 'VAPING',
WHEN THIS EXTENDS THE PERIODS
WHERE PTS COMBINE TOBACCO
SMOKING WITH NICOTINE RELIEF,
THIS WILL BE USELESS UNLESS IT
RESULTS IN PERMANENT
CESSATION
E-CIGARETTES NOR STOP
SMOKING MEDICINES CAN
PROVIDE A MAGIC SOLUTION
TO THE HARM SMOKING
BRINGS TO INDICIDUALS,
FAMILIES AND COMMUNITIES
ALONE
IF SMOKING IS BECOMING INCREASINGLY CONFINED TO
SMALL SOCIALLY AND ECONOMICALLY DISADVANTAGED
GROUPS & SELF-PURCHASED E-CIGARETTE USE IS
BELIEVED TO BE SAFE AND AFFORDABLE, THERE WILL BE A
DANGER THAT PUBLIC PROVISION OF OPTIMALLY
EFFECTIVE STOP SMOKING SERVICES WILL CONTINUE TO
DECLINE
NO. OF PEOPLE USING NHS STOP
SMOKING SERVICES AND SETTING
QUIT DATES HAS DECLINED BY
25% BETWEEN 2011/2012 TO
2013/2014
RECENT FIGURES
SUGGEST THAT THIS
FALL CONTINUES AND
THE DECLINE BETWEEN
2011/2012 AND 2014/2015
COULD REACH 50%
REASONS FOR FALL: INCREASED USE
OF E-CIGARETTES & NHS
REORGANISATION
INSUFFICIENT
INVESTMENT IN
ADVERTISING TO
STIMULATE THE USE
OF PROFESSIONAL
STOP SMOKING
REPORT MAY HAVE
CAUSED THIS
STRONG PUBLIC INTEREST
CASE FOR MAINTAINING
OPTIMALLY EFFECTIVE STOP
SMOKING SERVICES IN EVERY
LOCALITY & IMPROVING
THEIR APPEAL
CHALLENGE TO ADDRESS:
''FAILED QUITTER'
SYNDROME; COULD
DISCOURAGE THE UPTAKE OF
FORMAL CESSATION
SERVICES AND STOP
SMOKING MEDICINES
STRONG PUBLIC INTEREST
TO IMPROVE USE OF NRT &
OTHER SMOKING
CESSATION MEDICINES
TREATMENTS ARE CURRENTLY UNDER-USED ,
THEREFORE DOSES FAIL TO PROVIDE CLINICAL
BENEFIT
SUGGESTED STEP: TO ENCOURAGE
COMBINATION TREATMENTS &
DEVELOPMENT OF MEDICINES DESIGNED
TO SATISFY SMOKERS' CRAVINGS MORE
FULLY THAN CURRENT FORMS
DISAGREEMENTS ABOUT
SMOKING CESSATION &
HARM REDUCTION (WRT
E-CIGARETTES/NRT) MAY
DAMAGE COLLECTIVE
ABILITY TO INFORM
POLICY
IMPORTANT TO SEEK TO OPTIMISE USE OF ALL
METHODS AVAILABLE TO PURSUE GOAL OF
SMOKING CESSATION & REDUCING PREMATURE
DEATH & DISABILITY RATES
IN EUROPE, IMPLEMENTATION OF 2014
REVISED TOBACCO PRODUCTS
DIRECTIVE (TPD) WILL INTRODUCE
CONTROLS ON VAPING FLUIDS &
PRODUCTS AND FURTHER REGULATE
PROMOTION
HOWEVER, WITHOUT ADDITIONAL ACTIONS, THIS
WILL NOT ASSURE MANUFACTURE QUALITY OR
PROVIDE LEVEL OF SAFETY PROTECTION THE
MEDICINES REGULATIONS OFFER
'SMOKER CENTRED'
APPROACH COULD
EFFECTIVELY END TOBACCO
PANDEMIC IN ENGLAND
DURING 2040s
MOST PRESSING HEALTH POLICY OBJECTIVE
TODAY: REDUCE INCIDENCE OF CONDITION
SUCH AS CANCERS & COPD ASSOCIATED WITH
CIGARETTE SMOKING BY ALL EFFECTIVE
MEANS AVAILABLE
IMPORTANT TO RESPECT
INDIVIDUAL PREFERENCES
WRT USING DRUGS SUCH
AS NICOTINE FOR LEISURE
HOWEVER, IF HEALTH =
ACHIEVING A STATE OF
OPTIMAL MENTAL,
PHYSICAL & SOCIAL
WELLBEING AS MUCH AS
SIMPLY BEING FREE OF
DIAGNOSED DISEASE...
FACILITATING MASS NICOTINE
ADDICTION THROUGHOUT THE
21ST CENTURY COULD PROVE A
SUB-OPTIMAL SOCIETAL
CHOICE